Cargando…

Early and ongoing stable glycaemic control is associated with a reduction in major adverse cardiovascular events in people with type 2 diabetes: A primary care cohort study

AIM: To determine whether achieving early glycaemic control, and any subsequent glycaemic variability, was associated with any change in the risk of major adverse cardiovascular events (MACE). MATERIALS AND METHODS: A retrospective cohort analysis from the Oxford‐Royal College of General Practitione...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whyte, Martin B., Joy, Mark, Hinton, William, McGovern, Andrew, Hoang, Uy, van Vlymen, Jeremy, Ferreira, Filipa, Mount, Julie, Munro, Neil, de Lusignan, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320871/ https://www.ncbi.nlm.nih.gov/pubmed/35373891 http://dx.doi.org/10.1111/dom.14705

Ejemplares similares

Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis
por: Whyte, Martin B., et al.
Publicado: (2019)

Systematic review of adherence rates by medication class in type 2 diabetes: a study protocol
por: McGovern, Andrew, et al.
Publicado: (2016)

Real-world evidence studies into treatment adherence, thresholds for intervention and disparities in treatment in people with type 2 diabetes in the UK
por: McGovern, Andrew, et al.
Publicado: (2016)

A Class Comparison of Medication Persistence in People with Type 2 Diabetes: A Retrospective Observational Study
por: McGovern, Andrew, et al.
Publicado: (2018)

Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC) sentinel network: a cohort profile
por: Correa, Ana, et al.
Publicado: (2016)

Barriers and Facilitators to the Initiation of Injectable Therapies for Type 2 Diabetes Mellitus: A Mixed Methods Study
por: de Lusignan, Simon, et al.
Publicado: (2022)

Identification of people with autosomal dominant polycystic kidney disease using routine data: a cross sectional study
por: McGovern, Andrew P, et al.
Publicado: (2014)

Association of chronic kidney disease (CKD) and failure to monitor renal function with adverse outcomes in people with diabetes: a primary care cohort study
por: McGovern, Andrew P, et al.
Publicado: (2013)

Intensification to injectable therapy in type 2 diabetes: mixed methods study (protocol)
por: de Lusignan, Simon, et al.
Publicado: (2019)

Serum Phosphate as a Risk Factor for Cardiovascular Events in People with and without Chronic Kidney Disease: A Large Community Based Cohort Study
por: McGovern, Andrew Peter, et al.
Publicado: (2013)

Incidence and prevalence of cardiovascular disease in English primary care: a cross-sectional and follow-up study of the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC)
por: Hinton, William, et al.
Publicado: (2018)

Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors: Comparing Trial and Real World Use (Study Protocol)
por: McGovern, Andrew, et al.
Publicado: (2017)

Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor: Comparing Trial Data and Real-World Use
por: McGovern, Andrew, et al.
Publicado: (2017)

Valproate prescription to women of childbearing age in English primary care: repeated cross-sectional analyses and retrospective cohort study
por: Gaudio, Mariangela, et al.
Publicado: (2022)

Bariatric Surgery in Obese Women of Reproductive Age Improves Conditions That Underlie Fertility and Pregnancy Outcomes: Retrospective Cohort Study of UK National Bariatric Surgery Registry (NBSR)
por: Edison, Eric, et al.
Publicado: (2016)

U-shaped relationship between serum phosphate and cardiovascular risk: A retrospective cohort study
por: Hayward, Nicholas, et al.
Publicado: (2017)

Sodium–glucose co‐transporter‐2 inhibitor cardiovascular outcome trials and generalizability to English primary care
por: Hinton, W., et al.
Publicado: (2020)

Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosis
por: Hinton, William, et al.
Publicado: (2021)

The Effect of the COVID-19 Pandemic on Glycemic Monitoring and Other Processes of Care for Type 2 Diabetes: Protocol for a Retrospective Cohort Study
por: Mathew, Mekha, et al.
Publicado: (2022)

Fenofibrate as a COVID-19 modifying drug: Laboratory success versus real-world reality
por: Feher, Michael, et al.
Publicado: (2021)

Using Point of Care Testing to estimate influenza vaccine effectiveness in the English primary care sentinel surveillance network
por: de Lusignan, Simon, et al.
Publicado: (2021)

Incidence of household transmission of acute gastroenteritis (AGE) in a primary care sentinel network (1992–2017): cross-sectional and retrospective cohort study protocol
por: de Lusignan, Simon, et al.
Publicado: (2018)

Obstructive sleep apnoea in Type 2 diabetes mellitus: increased risk for overweight as well as obese people included in a national primary care database analysis
por: Feher, M., et al.
Publicado: (2019)

Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study)
por: Feher, Michael, et al.
Publicado: (2022)

Feasibility of Point-of-Care Testing for Influenza Within a National Primary Care Sentinel Surveillance Network in England: Protocol for a Mixed Methods Study
por: de Lusignan, Simon, et al.
Publicado: (2019)

Ongoing barriers to immediate postpartum long-acting reversible contraception: a physician survey
por: Holden, Emily C., et al.
Publicado: (2018)

Does Real World Use of Liraglutide Match its Use in the LEADER Cardiovascular Outcome Trial? Study Protocol
por: Hinton, William, et al.
Publicado: (2018)

Does Renal Function or Heart Failure Diagnosis Affect Primary Care Prescribing for Sodium-Glucose Co-Transporter 2 Inhibitors in Type 2 Diabetes?
por: Hinton, William, et al.
Publicado: (2020)

Perinatal Management of Major Congenital Heart Disease
por: McGovern, Eiméar, et al.
Publicado: (2014)

Ongoing Genome Reduction in Mycobacterium ulcerans
por: Rondini, Simona, et al.
Publicado: (2007)

Using an Ontology to Facilitate More Accurate Coding of Social Prescriptions Addressing Social Determinants of Health: Feasibility Study
por: Jani, Anant, et al.
Publicado: (2020)

How Generalizable Are Cardiovascular Outcome Trials of Sodium-Glucose Co-Transporter-2 Inhibitors? A National Database Study: Study Protocol
por: Hinton, William, et al.
Publicado: (2019)

Adverse Drug Events in the Elderly: An Ongoing Problem
por: Gray, Charnelda, et al.
Publicado: (2009)

Effect of type 1 diabetes and type 2 diabetes on the risk of venous thromboembolism
por: Hinton, William, et al.
Publicado: (2020)

Use and impact of social prescribing: a mixed-methods feasibility study protocol
por: Jani, Anant, et al.
Publicado: (2020)

Real‐world prevalence of the inclusion criteria for the LEADER trial: Data from a national general practice network
por: Hinton, William, et al.
Publicado: (2019)

Glycaemic variability and risk of adverse cardiovascular events in acute coronary syndrome
por: Zhang, Lei, et al.
Publicado: (2022)

The ALFA (Activity Log Files Aggregation) Toolkit: A Method for Precise Observation of the Consultation
por: de Lusignan, Simon, et al.
Publicado: (2008)

Integrating molecular point-of-care testing for influenza into primary care: a mixed-methods feasibility study
por: de Lusignan, Simon, et al.
Publicado: (2020)

Determinants of inter-practice variation in ADHD diagnosis and stimulant prescribing: cross-sectional database study of a national surveillance network
por: Hoang, Uy, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rasp6bqqq7u84qappf3o932pb6